HOME > 業績集 > Docetaxel and cisplatin as second-line chemotherapy for advanced non-small cell lung cancer. Docetaxel and cisplatin as second-line chemotherapy for advanced non-small cell lung cancer. 2007年10月01日 ← Overexpression of suppressor of cytokine signalling-5 augments eosinophilic airway inflammation in mice. Significance of serum uric acid in patients with chronic respiratory failure treated with non-invasive positive pressure ventilation. →